| 01/03 | | WATSON PHARMACEUTICALS, INC.: Watson's Generic Lysteda® Receives FDA Approval |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson Launches Generic Biaxin(R) XL |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson Receives FDA Approval For Oxycodone And Ac.. |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson Confirms Velcade® Patent Challenge |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson to Present at the 31st Annual J.P. Morgan .. |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson to Present at 2013 Goldman Sachs Healthcar.. |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson to Present at the 2012 Piper Jaffray Healt.. |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson's Generic Revatio® Receives FDA Approval |
| 2012 | DJ | FDA Panel Splits on Merck Plan to Sell Bladder Drug Over-The-Counter |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson to Present at the Jefferies 2012 Global He.. |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson to Present at the 2012 Annual Credit Suiss.. |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson Third Quarter 2012 Non-GAAP Diluted EPS In.. |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson Announces New Name -- Actavis -- for Globa.. |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson Completes Actavis Acquisition |
| 2012 |  | WATSON PHARMACEUTICALS, INC.: quaterly earnings release |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson Announces Sale of Rugby OTC Product Tradem.. |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson Receives FDA Approval for Generic Actos® |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson Confirms FDA Denies Appeal Related to Proc.. |
| 2012 | DJ | Mylan CEO Eyes Acquisitions Valued at More than $4 Billion |
| 2012 | DJ | Mylan CEO Eyes Acquisitions Valued at More than $4 Billion |
| 2012 | DJ | U.S. HOT STOCK FUTURES: Hot stocks to watch |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson Receives Favorable Court Decision Regardin.. |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson Sells Minority Shareholding Position in Mo.. |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson to Host Third Quarter 2012 Earnings Confer.. |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Actavis forecasts 2012 sales in excess of 2 billi.. |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Par to Acquire 14 Generic Products |
| 2012 | DJ | WATSON PHARMACEUTICALS, INC.: FTC Clears Watson-Actavis Deal, With Conditions |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson Receives FTC Clearance for Actavis Acquisi.. |
| 2012 | DJ | Watson Pharmaceuticals Gains FDA Approval for Two Generics |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson's Generic Sanctura XR® Receives FDA Appro.. |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson's Generic Avapro® Receives FDA Approval |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson Receives Approval from European Commission.. |
| 2012 | DJ | FDA Withdrawing Approval of 1 Impax/Teva Generic Wellbutrin Product |
| 2012 | | U.S. finds no wrongdoing in Yasmin patent settlement |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson Confirms Favorable District Court Ruling i.. |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson Prices $3.9 Billion of Senior Unsecured No.. |
| 2012 | DJ | Jumbo Deals Push Monthly Corporate Bond Volume to $115 Billion |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson Announces Offering of Senior Unsecured Not.. |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson Issues Voluntary Nationwide Recall of Hydr.. |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson to Present at the 2012 Bank of America Mer.. |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson to Present at the Morgan Stanley 2012 Glob.. |
| 2012 | DJ | U.S. HOT STOCK FUTURES: Hot stocks to watch |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson's Generic Lidoderm(R) Receives FDA Approva.. |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson Launches Generic Xopenex® |
| 2012 | DJ | Watson Pharma Sues FDA |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson Sues FDA Regarding Delay of Generic Actos®.. |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson Applauds GPhA Study Demonstrating $1 Trill.. |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson's Generic Version of Pulmicort RESPULES® R.. |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson Confirms Xopenox HFA® Patent Challenge |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson Confirms Epiduo® Gel Patent Challenge |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson Second Quarter 2012 Non-GAAP Diluted EPS I.. |
| 2012 | DJ | WATSON PHARMACEUTICALS: FDA Approves Generic of Teva's Plan B Emergency Contrac.. |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson's Generic Version of Plan B One-Step® Rece.. |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson and Actavis Receive FTC Second Request |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson's Generic ARTHROTEC(R) Receives FDA Approv.. |
| 2012 | DJ | Correction to Shire's Generic Adderall XR Approval Story On June 25 |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson to Host Second Quarter 2012 Earnings Confe.. |
| 2012 | DJ | West Virginia Attorney General Sues Drug Distributors in Pill Abuse Fight |
| 2012 | DJ | U.S. HOT STOCK FUTURES: Hot stocks to watch |
| 2012 | DJ | U.S. HOT STOCK FUTURES: Hot stocks to watch |
| 2012 | DJ | Watson Seeks FDA Approval Of Generic Pristiq |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson Confirms Pristiq® Patent Challenge |
| 2012 | DJ | Shire Sinks On Generic Adderall XR Approval But Rebound Seen |
| 2012 | | WATSON PHARMACEUTICALS, INC.: /C O R R E C T I O N -- Watson Pharmaceuticals, I.. |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson Confirms Favorable Appeals Court Decision .. |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson to Present at Goldman Sachs Global Healthc.. |
| 2012 | DJ | Mylan Launches Generic Version of Blockbuster Lipitor |
| 2012 | DJ | US HOT STOCK FUTURES: Hot stocks to watch |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson Announces Lidoderm® Patent Challenge Settl.. |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson to Present at the Jefferies 2012 Global He.. |
| 2012 | DJ | US HOT STOCK FUTURES: Hot stocks to watch |
| 2012 | DJ | US HOT STOCK FUTURES: Hot stocks to watch |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson Confirms Testim® Patent Challenge |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson to Present at the Sanford C. Bernstein 28t.. |
| 2012 | | WATSON PHARMACEUTICALS, INC.: Watson Confirms Lo Loestrin® Fe Patent Challenge |
Prev.
